Inventaire - twoi znajomi i społeczności to twoja najlepsza biblioteka

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

autor

Hiroyuki Aburatani

opublikowano w: Nature

data publikacji: 2007-08-02

język: język angielski

główny temat: rak płuca

Cites articles 24

Data

Tytuł

Autorzy

2007-03-19

Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening
2006

Cancer statistics, 2006
2006-06-21

Identification of a constitutively active mutant of JAK3 by retroviral expression screening

Young Lim Choi, Ruri Kaneda, Yoshihiro Yamashita
2006-07-08

Human EML4, a novel member of the EMAP family, is essential for microtubule formation
2006-12-21

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

Peter G. Schultz, Nathanael Gray
2006-02-01

Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase
2005-10-24

Transforming activity of the lymphotoxin-beta receptor revealed by expression screening

Ruri Kaneda, Young Lim Choi, Yoshihiro Yamashita
2005-06-01

Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity

Carlo Gambacorti-Passerini, Leonardo Scapozza
2005-12-01

Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3

Michal Marzec, Paweł Włodarski, Mariusz A. Wąsik
2004-05-20

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Daniel Haber, David C. Christiani
2004-06-04

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

Heidi Greulich, Stacey Gabriel, Matthew Meyerson, Pasi A Jänne, Titus J Boggon
2004-09-07

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Harold Varmus, William Pao, Lucinda Fulton, Elaine Mardis, Mark G Kris, Valerie W Rusch, Katerina Politi
2004-08-11

An alternative transcript derived from the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential
2004-06-01

Anaplastic lymphoma kinase proteins in growth control and cancer
2002-01-01

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Chandra Belani, Corey J Langer
2002-01-11

The human EMAP-like protein-70 (ELP70) is a microtubule destabilizer that localizes to the mitotic apparatus

Kathy A. Suprenant
2002-04

Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity

German Ott, Andreas Rosenwald
2001-04-05

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
2001-09-01

Translocations involving anaplastic lymphoma kinase (ALK).
2001-08-06

Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase
1999-05

The WD repeat: a common architecture for diverse functions
1996-05-01

JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells

Tohru Itoh
1994-03-04

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
1985-07-01

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

Artykuł - wd:Q27851410

Witaj w Inventaire

biblioteka twoich znajomych i społeczności

dowiedz się więcej